COMMUNIQUÉS West-GlobeNewswire
-
TME Pharma fait le point sur ses activités
24/08/2026 -
TME Pharma provides update on its activities
24/08/2026 -
First Patient Treated in PIONEER-1 Registrational Trial of Privosegtor for Optic Neuritis
24/08/2026 -
First Patient Treated in PIONEER-1 Registrational Trial of Privosegtor for Optic Neuritis
24/08/2026 -
NRG Therapeutics Presents Data on Lead Clinical Asset NRG5051 Confirming Novel Disease-Modifying Approach to ALS
24/08/2026 -
New EON hearing aid portfolio strengthens Phonak’s leadership in speech understanding, scene intelligence and Made-For-All connectivity
24/08/2026 -
Orum Therapeutics Announces U.S. FDA Clearance of an IND Application for ORM-1153, a Novel CD123-GSPT1 Degrader-Antibody Conjugate
23/08/2026 -
UPDATE Integrity Urgent Care Clinic Opens in Murphy, Texas
22/08/2026 -
Report on transactions with ALK-Abelló A/S B shares and associated securities by managerial staff
22/08/2026 -
Amended Notice of Secured Party Public Sale of Personal Property of XEVANT, INC.
22/08/2026 -
The Baja Is Back: A Race Against Blindness Offers One Final Chance to Win $350,000 Adventure Truck Prize
22/08/2026 -
Bioengineered blood vessel for Coronary Bypass Sustains 18-Month Patency — With a Full Year without Blood Thinners
21/08/2026 -
NurExone Announces Annual General and Special Meeting to Consider Share Consolidation in Support of U.S. Capital Markets Strategy
21/08/2026 -
Zevra Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
21/08/2026 -
Jury Finds in Cytek’s Favor on Three of Four Asserted Claims; Company to Challenge Remaining Finding
21/08/2026 -
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
21/08/2026 -
Memodyne Details 2026 Cognitive Formula Ingredient Profile Featuring L-Arginine, L-Citrulline, and Niacin
21/08/2026 -
Vireo Growth Inc. Completes Acquisition of C21 Investments Inc.
21/08/2026 -
NMDP Ranks Second in its Sixth Consecutive ‘Best Places to Work’ Recognition
21/08/2026
Pages